Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia
Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study's aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS). A total...
Gespeichert in:
| Veröffentlicht in: | CARDIOVASCULAR DIABETOLOGY 2015-09, Vol.14 (1), p.120-120, Article 120 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 120 |
|---|---|
| container_issue | 1 |
| container_start_page | 120 |
| container_title | CARDIOVASCULAR DIABETOLOGY |
| container_volume | 14 |
| creator | Kuhl, Jeanette Jörneskog, Gun Wemminger, Malin Bengtsson, Mattias Lundman, Pia Kalani, Majid |
| description | Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study's aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS).
A total 1062 consecutive patients, 781 men and 281 women, aged 32-80 years, admitted to the coronary care unit at Danderyd University Hospital, Stockholm, for ACS from 2006 to 2008 were included. At discharge, the patients were categorized according to an oral glucose tolerance test (OGTT) as having normal glucose tolerance (NGT), n = 295 (28%); impaired fasting glucose (IFG) and IGT, n = 299 (28%); diabetes discovered by OGTT, n = 156 (15%); or known diabetes at admission, n = 312 (29%). Mortality and reinfarction rates were studied during a mean follow-up time of 4.0 (±0.8) years. Clinical outcome data were obtained from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish National Registry.
There was significantly higher (p < 0.001) mortality within, 30 days, 1 and 3 years in patients with known diabetes as compared to the other groups. During the follow-up, 86 patients (28%) with known diabetes had reinfarction as compared to 36 patients (12%) with NGT and 79 patients (17%) with dysglycaemia (IFG, IGT and diabetes) discovered by OGTT.
A majority (72% in this study) of patients admitted for ACS have disturbed glucose metabolism, including diabetes, with high prevalence of previously undiagnosed dysglycaemia. Both patients with known diabetes and dysglycaemia discovered by OGTT show a high risk for poor clinical prognosis. |
| doi_str_mv | 10.1186/s12933-015-0283-3 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_510637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541470453</galeid><sourcerecordid>A541470453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-7b032fbf45207ae145adbebe50a6e545f92a528764a213dbab6de7e3b5da21fb3</originalsourceid><addsrcrecordid>eNpdUk1v1DAQjRCIlrY_gAuyxKUXF3_G3gtSVVFAWolLOVuOPdm6JPZiJ1T773GUpWqRDx7NvPc8M35N856SK0p1-6lQtuEcEyoxYZpj_qo5pUJJzLQgr5_FJ827Uh4IoUq39G1zwlqumVT6tLnbprjDE-QRuSHE4OyA0jy5NAIKEe3tFCBOBT2G6R5ZN0-AXMop2nxA5RB9XoA2euQPZTccnIUx2PPmTW-HAhfH-6z5efvl7uYb3v74-v3meoud5GzCqiOc9V0vJCPKAhXS-g46kMS2IIXsN8xKplUrLKPcd7ZrPSjgnfQ10Xf8rMGrbnmE_dyZfQ5jbcwkG8wx9atGYCQlLVcV_3nF18oI3tXJsh1e0F5WYrg3u_THCKkE0boKXB4Fcvo9Q5nMGIqDYbAR0lwMVVRuqJScV-jH_6APac6xrqOiNCFKtEJU1NWK2tkBTIh9qu-6enzdo0sR-lDz11LUryRCLrJ0JbicSsnQP3VPiVlMYVZTmGoKs5jCLJwPz8d-YvxzAf8LKUS0hA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780074644</pqid></control><display><type>article</type><title>Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SWEPUB Freely available online</source><source>SpringerLink Journals - AutoHoldings</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Kuhl, Jeanette ; Jörneskog, Gun ; Wemminger, Malin ; Bengtsson, Mattias ; Lundman, Pia ; Kalani, Majid</creator><creatorcontrib>Kuhl, Jeanette ; Jörneskog, Gun ; Wemminger, Malin ; Bengtsson, Mattias ; Lundman, Pia ; Kalani, Majid</creatorcontrib><description>Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study's aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS).
A total 1062 consecutive patients, 781 men and 281 women, aged 32-80 years, admitted to the coronary care unit at Danderyd University Hospital, Stockholm, for ACS from 2006 to 2008 were included. At discharge, the patients were categorized according to an oral glucose tolerance test (OGTT) as having normal glucose tolerance (NGT), n = 295 (28%); impaired fasting glucose (IFG) and IGT, n = 299 (28%); diabetes discovered by OGTT, n = 156 (15%); or known diabetes at admission, n = 312 (29%). Mortality and reinfarction rates were studied during a mean follow-up time of 4.0 (±0.8) years. Clinical outcome data were obtained from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish National Registry.
There was significantly higher (p < 0.001) mortality within, 30 days, 1 and 3 years in patients with known diabetes as compared to the other groups. During the follow-up, 86 patients (28%) with known diabetes had reinfarction as compared to 36 patients (12%) with NGT and 79 patients (17%) with dysglycaemia (IFG, IGT and diabetes) discovered by OGTT.
A majority (72% in this study) of patients admitted for ACS have disturbed glucose metabolism, including diabetes, with high prevalence of previously undiagnosed dysglycaemia. Both patients with known diabetes and dysglycaemia discovered by OGTT show a high risk for poor clinical prognosis.</description><identifier>ISSN: 1475-2840</identifier><identifier>EISSN: 1475-2840</identifier><identifier>DOI: 10.1186/s12933-015-0283-3</identifier><identifier>PMID: 26382578</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acute Coronary Syndrome - diagnosis ; Acute Coronary Syndrome - mortality ; Acute Coronary Syndrome - therapy ; Adult ; Aged ; Aged, 80 and over ; Analysis ; Biomarkers - blood ; Blood Glucose - metabolism ; Care and treatment ; Clinical outcomes ; Complications and side effects ; Coronary Angiography ; Coronary Artery Bypass - adverse effects ; Coronary Artery Bypass - mortality ; Coronary Care Units ; Evidence-based medicine ; Female ; Glucose metabolism ; Glucose Metabolism Disorders - blood ; Glucose Metabolism Disorders - diagnosis ; Glucose Metabolism Disorders - mortality ; Glucose Tolerance Test ; Hospitals, University ; Humans ; Kaplan-Meier Estimate ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Myocardial Infarction - diagnosis ; Myocardial Infarction - mortality ; Myocardial Infarction - therapy ; Original Investigation ; Patient outcomes ; Percutaneous Coronary Intervention - adverse effects ; Percutaneous Coronary Intervention - mortality ; Prevalence ; Recurrence ; Registries ; Retrospective Studies ; Risk Factors ; Sweden - epidemiology ; Time Factors ; Treatment Outcome ; Type 2 diabetes</subject><ispartof>CARDIOVASCULAR DIABETOLOGY, 2015-09, Vol.14 (1), p.120-120, Article 120</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2015</rights><rights>Kuhl et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-7b032fbf45207ae145adbebe50a6e545f92a528764a213dbab6de7e3b5da21fb3</citedby><cites>FETCH-LOGICAL-c532t-7b032fbf45207ae145adbebe50a6e545f92a528764a213dbab6de7e3b5da21fb3</cites><orcidid>0000-0002-9938-5291</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574088/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574088/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26382578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:131996754$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuhl, Jeanette</creatorcontrib><creatorcontrib>Jörneskog, Gun</creatorcontrib><creatorcontrib>Wemminger, Malin</creatorcontrib><creatorcontrib>Bengtsson, Mattias</creatorcontrib><creatorcontrib>Lundman, Pia</creatorcontrib><creatorcontrib>Kalani, Majid</creatorcontrib><title>Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia</title><title>CARDIOVASCULAR DIABETOLOGY</title><addtitle>Cardiovasc Diabetol</addtitle><description>Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study's aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS).
A total 1062 consecutive patients, 781 men and 281 women, aged 32-80 years, admitted to the coronary care unit at Danderyd University Hospital, Stockholm, for ACS from 2006 to 2008 were included. At discharge, the patients were categorized according to an oral glucose tolerance test (OGTT) as having normal glucose tolerance (NGT), n = 295 (28%); impaired fasting glucose (IFG) and IGT, n = 299 (28%); diabetes discovered by OGTT, n = 156 (15%); or known diabetes at admission, n = 312 (29%). Mortality and reinfarction rates were studied during a mean follow-up time of 4.0 (±0.8) years. Clinical outcome data were obtained from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish National Registry.
There was significantly higher (p < 0.001) mortality within, 30 days, 1 and 3 years in patients with known diabetes as compared to the other groups. During the follow-up, 86 patients (28%) with known diabetes had reinfarction as compared to 36 patients (12%) with NGT and 79 patients (17%) with dysglycaemia (IFG, IGT and diabetes) discovered by OGTT.
A majority (72% in this study) of patients admitted for ACS have disturbed glucose metabolism, including diabetes, with high prevalence of previously undiagnosed dysglycaemia. Both patients with known diabetes and dysglycaemia discovered by OGTT show a high risk for poor clinical prognosis.</description><subject>Acute Coronary Syndrome - diagnosis</subject><subject>Acute Coronary Syndrome - mortality</subject><subject>Acute Coronary Syndrome - therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Complications and side effects</subject><subject>Coronary Angiography</subject><subject>Coronary Artery Bypass - adverse effects</subject><subject>Coronary Artery Bypass - mortality</subject><subject>Coronary Care Units</subject><subject>Evidence-based medicine</subject><subject>Female</subject><subject>Glucose metabolism</subject><subject>Glucose Metabolism Disorders - blood</subject><subject>Glucose Metabolism Disorders - diagnosis</subject><subject>Glucose Metabolism Disorders - mortality</subject><subject>Glucose Tolerance Test</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - therapy</subject><subject>Original Investigation</subject><subject>Patient outcomes</subject><subject>Percutaneous Coronary Intervention - adverse effects</subject><subject>Percutaneous Coronary Intervention - mortality</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sweden - epidemiology</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Type 2 diabetes</subject><issn>1475-2840</issn><issn>1475-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><recordid>eNpdUk1v1DAQjRCIlrY_gAuyxKUXF3_G3gtSVVFAWolLOVuOPdm6JPZiJ1T773GUpWqRDx7NvPc8M35N856SK0p1-6lQtuEcEyoxYZpj_qo5pUJJzLQgr5_FJ827Uh4IoUq39G1zwlqumVT6tLnbprjDE-QRuSHE4OyA0jy5NAIKEe3tFCBOBT2G6R5ZN0-AXMop2nxA5RB9XoA2euQPZTccnIUx2PPmTW-HAhfH-6z5efvl7uYb3v74-v3meoud5GzCqiOc9V0vJCPKAhXS-g46kMS2IIXsN8xKplUrLKPcd7ZrPSjgnfQ10Xf8rMGrbnmE_dyZfQ5jbcwkG8wx9atGYCQlLVcV_3nF18oI3tXJsh1e0F5WYrg3u_THCKkE0boKXB4Fcvo9Q5nMGIqDYbAR0lwMVVRuqJScV-jH_6APac6xrqOiNCFKtEJU1NWK2tkBTIh9qu-6enzdo0sR-lDz11LUryRCLrJ0JbicSsnQP3VPiVlMYVZTmGoKs5jCLJwPz8d-YvxzAf8LKUS0hA</recordid><startdate>20150917</startdate><enddate>20150917</enddate><creator>Kuhl, Jeanette</creator><creator>Jörneskog, Gun</creator><creator>Wemminger, Malin</creator><creator>Bengtsson, Mattias</creator><creator>Lundman, Pia</creator><creator>Kalani, Majid</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-9938-5291</orcidid></search><sort><creationdate>20150917</creationdate><title>Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia</title><author>Kuhl, Jeanette ; Jörneskog, Gun ; Wemminger, Malin ; Bengtsson, Mattias ; Lundman, Pia ; Kalani, Majid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-7b032fbf45207ae145adbebe50a6e545f92a528764a213dbab6de7e3b5da21fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Coronary Syndrome - diagnosis</topic><topic>Acute Coronary Syndrome - mortality</topic><topic>Acute Coronary Syndrome - therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Complications and side effects</topic><topic>Coronary Angiography</topic><topic>Coronary Artery Bypass - adverse effects</topic><topic>Coronary Artery Bypass - mortality</topic><topic>Coronary Care Units</topic><topic>Evidence-based medicine</topic><topic>Female</topic><topic>Glucose metabolism</topic><topic>Glucose Metabolism Disorders - blood</topic><topic>Glucose Metabolism Disorders - diagnosis</topic><topic>Glucose Metabolism Disorders - mortality</topic><topic>Glucose Tolerance Test</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - therapy</topic><topic>Original Investigation</topic><topic>Patient outcomes</topic><topic>Percutaneous Coronary Intervention - adverse effects</topic><topic>Percutaneous Coronary Intervention - mortality</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sweden - epidemiology</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuhl, Jeanette</creatorcontrib><creatorcontrib>Jörneskog, Gun</creatorcontrib><creatorcontrib>Wemminger, Malin</creatorcontrib><creatorcontrib>Bengtsson, Mattias</creatorcontrib><creatorcontrib>Lundman, Pia</creatorcontrib><creatorcontrib>Kalani, Majid</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>CARDIOVASCULAR DIABETOLOGY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuhl, Jeanette</au><au>Jörneskog, Gun</au><au>Wemminger, Malin</au><au>Bengtsson, Mattias</au><au>Lundman, Pia</au><au>Kalani, Majid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia</atitle><jtitle>CARDIOVASCULAR DIABETOLOGY</jtitle><addtitle>Cardiovasc Diabetol</addtitle><date>2015-09-17</date><risdate>2015</risdate><volume>14</volume><issue>1</issue><spage>120</spage><epage>120</epage><pages>120-120</pages><artnum>120</artnum><issn>1475-2840</issn><eissn>1475-2840</eissn><abstract>Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study's aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS).
A total 1062 consecutive patients, 781 men and 281 women, aged 32-80 years, admitted to the coronary care unit at Danderyd University Hospital, Stockholm, for ACS from 2006 to 2008 were included. At discharge, the patients were categorized according to an oral glucose tolerance test (OGTT) as having normal glucose tolerance (NGT), n = 295 (28%); impaired fasting glucose (IFG) and IGT, n = 299 (28%); diabetes discovered by OGTT, n = 156 (15%); or known diabetes at admission, n = 312 (29%). Mortality and reinfarction rates were studied during a mean follow-up time of 4.0 (±0.8) years. Clinical outcome data were obtained from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish National Registry.
There was significantly higher (p < 0.001) mortality within, 30 days, 1 and 3 years in patients with known diabetes as compared to the other groups. During the follow-up, 86 patients (28%) with known diabetes had reinfarction as compared to 36 patients (12%) with NGT and 79 patients (17%) with dysglycaemia (IFG, IGT and diabetes) discovered by OGTT.
A majority (72% in this study) of patients admitted for ACS have disturbed glucose metabolism, including diabetes, with high prevalence of previously undiagnosed dysglycaemia. Both patients with known diabetes and dysglycaemia discovered by OGTT show a high risk for poor clinical prognosis.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26382578</pmid><doi>10.1186/s12933-015-0283-3</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9938-5291</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1475-2840 |
| ispartof | CARDIOVASCULAR DIABETOLOGY, 2015-09, Vol.14 (1), p.120-120, Article 120 |
| issn | 1475-2840 1475-2840 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_510637 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SWEPUB Freely available online; SpringerLink Journals - AutoHoldings; PubMed Central Open Access; Springer Nature OA Free Journals |
| subjects | Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - mortality Acute Coronary Syndrome - therapy Adult Aged Aged, 80 and over Analysis Biomarkers - blood Blood Glucose - metabolism Care and treatment Clinical outcomes Complications and side effects Coronary Angiography Coronary Artery Bypass - adverse effects Coronary Artery Bypass - mortality Coronary Care Units Evidence-based medicine Female Glucose metabolism Glucose Metabolism Disorders - blood Glucose Metabolism Disorders - diagnosis Glucose Metabolism Disorders - mortality Glucose Tolerance Test Hospitals, University Humans Kaplan-Meier Estimate Male Medical research Medicine, Experimental Middle Aged Myocardial Infarction - diagnosis Myocardial Infarction - mortality Myocardial Infarction - therapy Original Investigation Patient outcomes Percutaneous Coronary Intervention - adverse effects Percutaneous Coronary Intervention - mortality Prevalence Recurrence Registries Retrospective Studies Risk Factors Sweden - epidemiology Time Factors Treatment Outcome Type 2 diabetes |
| title | Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A38%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20clinical%20outcome%20in%20patients%20with%20acute%20coronary%20syndrome%20and%20dysglycaemia&rft.jtitle=CARDIOVASCULAR%20DIABETOLOGY&rft.au=Kuhl,%20Jeanette&rft.date=2015-09-17&rft.volume=14&rft.issue=1&rft.spage=120&rft.epage=120&rft.pages=120-120&rft.artnum=120&rft.issn=1475-2840&rft.eissn=1475-2840&rft_id=info:doi/10.1186/s12933-015-0283-3&rft_dat=%3Cgale_swepu%3EA541470453%3C/gale_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780074644&rft_id=info:pmid/26382578&rft_galeid=A541470453&rfr_iscdi=true |